scispace - formally typeset
M

Mark A. Magnuson

Researcher at Vanderbilt University

Publications -  260
Citations -  32767

Mark A. Magnuson is an academic researcher from Vanderbilt University. The author has contributed to research in topics: Glucokinase & Insulin. The author has an hindex of 100, co-authored 249 publications receiving 30668 citations. Previous affiliations of Mark A. Magnuson include Ninewells Hospital & University of Texas Southwestern Medical Center.

Papers
More filters
Journal ArticleDOI

PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum

TL;DR: The pdx-1/beta-galactosidase fusion allele is expressed in pancreatic and duodenal cells in the absence of functional PDX-1, with expression continuing into perinatal stages with similar boundaries and expression levels, and offers additional insight into the role of p dx-1 in the determination and differentiation of the posterior foregut.
Journal ArticleDOI

Loss of Insulin Signaling in Hepatocytes Leads to Severe Insulin Resistance and Progressive Hepatic Dysfunction

TL;DR: In this paper, the Cre-loxP system was used to inactivate the insulin receptor gene in hepatocytes, and the effect of the loss of direct insulin action in liver was investigated.
Journal ArticleDOI

Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase.

TL;DR: These studies indicate that deficiencies in both β cell and hepatic GK contribute to the hyperglycemia of MODY-2, and suggest that heterozygous null for GK, either globally or just in the β cell, survive but are moderately hyperglycemic.
Journal ArticleDOI

Tissue-Specific Knockout of the Insulin Receptor in Pancreatic β Cells Creates an Insulin Secretory Defect Similar to that in Type 2 Diabetes

TL;DR: An important functional role for the insulin receptor in glucose sensing by the pancreatic beta cell is indicated and it is suggested that defects in insulin signaling at the level of the beta cell may contribute to the observed alterations in insulin secretion in type 2 diabetes.